Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health?

Ronald A. Kohanski, Steven G. Deeks, Claudia Gravekamp, Jeffrey B. Halter, Kevin High, Arti Hurria, Rebecca Fuldner, Paige Green, Robin Huebner, Francesca Macchiarini, Felipe Sierra

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Aging is the major risk factor for both the development of chronic diseases and loss of functional capacity. Geroscience provides links among the biology of aging, the biology of disease, and the physiology of frailty, three fields where enormous progress has been made in the last few decades. While, previously, the focus was on the role of aging in susceptibility to disease and disability, the other side of this relationship, which is the contribution of disease to aging, has been less explored at the molecular/cellular level. Indeed, the role of childhood or early adulthood exposure to chronic disease and/or treatment on accelerating aging phenotypes is well known in epidemiology, but the biological basis is poorly understood. A recent summit co-organized by the National Institutes of Health GeroScience Interest Group and the New York Academy of Sciences explored these relationships, using three chronic diseases as examples: cancer, HIV/AIDS, and diabetes. The epidemiological literature clearly indicates that early exposure to any of these diseases and/or their treatments results in an acceleration of the appearance of aging phenotypes, including loss of functional capacity and accelerated appearance of clinical symptoms of aging-related diseases not obviously related to the earlier event. The discussions at the summit focused on the molecular and cellular relationships between each of these diseases and the recently defined molecular and cellular pillars of aging. Two major conclusions from the meeting include the desire to refine an operational definition of aging and to concomitantly develop biomarkers of aging, in order to move from chronological to physiological age. The discussion also opened a dialogue on the possibility of improving late-life outcomes in patients affected by chronic disease by including age-delaying modalities along with the standard care for the disease in question.

Original languageEnglish (US)
Pages (from-to)30-44
Number of pages15
JournalAnnals of the New York Academy of Sciences
Volume1386
Issue number1
DOIs
StatePublished - Dec 1 2016

Fingerprint

Health
Aging of materials
Chronic Disease
Phenotype
Public Opinion
Cell Aging
Disease Susceptibility
National Institutes of Health (U.S.)
Acquired Immunodeficiency Syndrome
Epidemiology
Biomarkers
HIV
Physiology
Medical problems
Therapeutics
Neoplasms

Keywords

  • aging
  • AIDS
  • cancer
  • diabetes
  • geroscience
  • HIV

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Reverse geroscience : how does exposure to early diseases accelerate the age-related decline in health? / Kohanski, Ronald A.; Deeks, Steven G.; Gravekamp, Claudia; Halter, Jeffrey B.; High, Kevin; Hurria, Arti; Fuldner, Rebecca; Green, Paige; Huebner, Robin; Macchiarini, Francesca; Sierra, Felipe.

In: Annals of the New York Academy of Sciences, Vol. 1386, No. 1, 01.12.2016, p. 30-44.

Research output: Contribution to journalArticle

Kohanski, RA, Deeks, SG, Gravekamp, C, Halter, JB, High, K, Hurria, A, Fuldner, R, Green, P, Huebner, R, Macchiarini, F & Sierra, F 2016, 'Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health?', Annals of the New York Academy of Sciences, vol. 1386, no. 1, pp. 30-44. https://doi.org/10.1111/nyas.13297
Kohanski, Ronald A. ; Deeks, Steven G. ; Gravekamp, Claudia ; Halter, Jeffrey B. ; High, Kevin ; Hurria, Arti ; Fuldner, Rebecca ; Green, Paige ; Huebner, Robin ; Macchiarini, Francesca ; Sierra, Felipe. / Reverse geroscience : how does exposure to early diseases accelerate the age-related decline in health?. In: Annals of the New York Academy of Sciences. 2016 ; Vol. 1386, No. 1. pp. 30-44.
@article{daeb5c0f35fe4425a9400c993b2c15d3,
title = "Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health?",
abstract = "Aging is the major risk factor for both the development of chronic diseases and loss of functional capacity. Geroscience provides links among the biology of aging, the biology of disease, and the physiology of frailty, three fields where enormous progress has been made in the last few decades. While, previously, the focus was on the role of aging in susceptibility to disease and disability, the other side of this relationship, which is the contribution of disease to aging, has been less explored at the molecular/cellular level. Indeed, the role of childhood or early adulthood exposure to chronic disease and/or treatment on accelerating aging phenotypes is well known in epidemiology, but the biological basis is poorly understood. A recent summit co-organized by the National Institutes of Health GeroScience Interest Group and the New York Academy of Sciences explored these relationships, using three chronic diseases as examples: cancer, HIV/AIDS, and diabetes. The epidemiological literature clearly indicates that early exposure to any of these diseases and/or their treatments results in an acceleration of the appearance of aging phenotypes, including loss of functional capacity and accelerated appearance of clinical symptoms of aging-related diseases not obviously related to the earlier event. The discussions at the summit focused on the molecular and cellular relationships between each of these diseases and the recently defined molecular and cellular pillars of aging. Two major conclusions from the meeting include the desire to refine an operational definition of aging and to concomitantly develop biomarkers of aging, in order to move from chronological to physiological age. The discussion also opened a dialogue on the possibility of improving late-life outcomes in patients affected by chronic disease by including age-delaying modalities along with the standard care for the disease in question.",
keywords = "aging, AIDS, cancer, diabetes, geroscience, HIV",
author = "Kohanski, {Ronald A.} and Deeks, {Steven G.} and Claudia Gravekamp and Halter, {Jeffrey B.} and Kevin High and Arti Hurria and Rebecca Fuldner and Paige Green and Robin Huebner and Francesca Macchiarini and Felipe Sierra",
year = "2016",
month = "12",
day = "1",
doi = "10.1111/nyas.13297",
language = "English (US)",
volume = "1386",
pages = "30--44",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Reverse geroscience

T2 - how does exposure to early diseases accelerate the age-related decline in health?

AU - Kohanski, Ronald A.

AU - Deeks, Steven G.

AU - Gravekamp, Claudia

AU - Halter, Jeffrey B.

AU - High, Kevin

AU - Hurria, Arti

AU - Fuldner, Rebecca

AU - Green, Paige

AU - Huebner, Robin

AU - Macchiarini, Francesca

AU - Sierra, Felipe

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Aging is the major risk factor for both the development of chronic diseases and loss of functional capacity. Geroscience provides links among the biology of aging, the biology of disease, and the physiology of frailty, three fields where enormous progress has been made in the last few decades. While, previously, the focus was on the role of aging in susceptibility to disease and disability, the other side of this relationship, which is the contribution of disease to aging, has been less explored at the molecular/cellular level. Indeed, the role of childhood or early adulthood exposure to chronic disease and/or treatment on accelerating aging phenotypes is well known in epidemiology, but the biological basis is poorly understood. A recent summit co-organized by the National Institutes of Health GeroScience Interest Group and the New York Academy of Sciences explored these relationships, using three chronic diseases as examples: cancer, HIV/AIDS, and diabetes. The epidemiological literature clearly indicates that early exposure to any of these diseases and/or their treatments results in an acceleration of the appearance of aging phenotypes, including loss of functional capacity and accelerated appearance of clinical symptoms of aging-related diseases not obviously related to the earlier event. The discussions at the summit focused on the molecular and cellular relationships between each of these diseases and the recently defined molecular and cellular pillars of aging. Two major conclusions from the meeting include the desire to refine an operational definition of aging and to concomitantly develop biomarkers of aging, in order to move from chronological to physiological age. The discussion also opened a dialogue on the possibility of improving late-life outcomes in patients affected by chronic disease by including age-delaying modalities along with the standard care for the disease in question.

AB - Aging is the major risk factor for both the development of chronic diseases and loss of functional capacity. Geroscience provides links among the biology of aging, the biology of disease, and the physiology of frailty, three fields where enormous progress has been made in the last few decades. While, previously, the focus was on the role of aging in susceptibility to disease and disability, the other side of this relationship, which is the contribution of disease to aging, has been less explored at the molecular/cellular level. Indeed, the role of childhood or early adulthood exposure to chronic disease and/or treatment on accelerating aging phenotypes is well known in epidemiology, but the biological basis is poorly understood. A recent summit co-organized by the National Institutes of Health GeroScience Interest Group and the New York Academy of Sciences explored these relationships, using three chronic diseases as examples: cancer, HIV/AIDS, and diabetes. The epidemiological literature clearly indicates that early exposure to any of these diseases and/or their treatments results in an acceleration of the appearance of aging phenotypes, including loss of functional capacity and accelerated appearance of clinical symptoms of aging-related diseases not obviously related to the earlier event. The discussions at the summit focused on the molecular and cellular relationships between each of these diseases and the recently defined molecular and cellular pillars of aging. Two major conclusions from the meeting include the desire to refine an operational definition of aging and to concomitantly develop biomarkers of aging, in order to move from chronological to physiological age. The discussion also opened a dialogue on the possibility of improving late-life outcomes in patients affected by chronic disease by including age-delaying modalities along with the standard care for the disease in question.

KW - aging

KW - AIDS

KW - cancer

KW - diabetes

KW - geroscience

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=85006321386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006321386&partnerID=8YFLogxK

U2 - 10.1111/nyas.13297

DO - 10.1111/nyas.13297

M3 - Article

C2 - 27907230

AN - SCOPUS:85006321386

VL - 1386

SP - 30

EP - 44

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -